Researchers performed a retrospective cohort study by identifying patients from the Optum Clinformatics database who were initiated on canagliflozin 300mg or dapagliflozin 100mg from January 1, 2014 to September 30, 2016.
SGLT2 Inhibitors Canagliflozin, Dapagliflozin Compared in Real-World Study posted first on https://www.youtube.com/dailyhealthpost/
No comments:
Post a Comment